NASDAQ:NMTC

NeuroOne Medical Technologies - NMTC Stock Forecast, Price & News

$1.72

-0.03 (-1.71%)

(As of 09/28/2022 12:00 AM ET)

Add

Compare

Today's Range: $1.70
▼
$1.79
50-Day Range: $1.03
▼
$2.55
52-Week Range: $0.51
▼
$4.25

Volume: 9,262 shs
Average Volume: 140,808 shs
Market Capitalization: $27.88 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $2.63

NeuroOne Medical Technologies MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 52.6% Upside
$2.63 Price Target
Short Interest: Healthy
0.36% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.69
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

823rd out of 1,096 stocks

Surgical & Medical Instruments Industry

83rd out of 108 stocks

3.3

Analyst's Opinion

Consensus Rating
NeuroOne Medical Technologies has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $2.63, NeuroOne Medical Technologies has a forecasted upside of 52.6% from its current price of $1.72.
Amount of Analyst Coverage
NeuroOne Medical Technologies has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
0.36% of the float of NeuroOne Medical Technologies has been sold short.
Short Interest Ratio / Days to Cover
NeuroOne Medical Technologies has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in NeuroOne Medical Technologies has recently decreased by 2.39%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
NeuroOne Medical Technologies does not currently pay a dividend.
Dividend Growth
NeuroOne Medical Technologies does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NMTC.

3.2

News and Social Media Coverage

News Sentiment
NeuroOne Medical Technologies has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for NeuroOne Medical Technologies this week, compared to 0 articles on an average week.
Search Interest
12 people have searched for NMTC on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
MarketBeat Follows
9 people have added NeuroOne Medical Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 80% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, NeuroOne Medical Technologies insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 7.60% of the stock of NeuroOne Medical Technologies is held by insiders.
Percentage Held by Institutions
Only 2.55% of the stock of NeuroOne Medical Technologies is held by institutions.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of NeuroOne Medical Technologies is -2.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of NeuroOne Medical Technologies is -2.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
NeuroOne Medical Technologies has a P/B Ratio of 3.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About NeuroOne Medical Technologies (NASDAQ:NMTC) Stock

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.

Receive NMTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

NMTC Stock News Headlines

September 18, 2022 | americanbankingnews.com

NeuroOne Medical Technologies (NASDAQ:NMTC) Trading Down 8.4%

September 15, 2022 | nasdaq.com

Will NeuroOne Medical Technologies (NASDAQ:NMTC) Spend Its Cash Wisely?

August 22, 2022 | finance.yahoo.com

Is NeuroOne Medical Technologies (NASDAQ:NMTC) In A Good Position To Deliver On Growth Plans?

August 14, 2022 | seekingalpha.com

NeuroOne Medical Technologies Corporation (NMTC) CEO Dave Rosa on Q3 2022 Results - Earnings Call Transcript

August 13, 2022 | seekingalpha.com

NeuroOne Medical Technologies Corporation reports FQ3 results

August 11, 2022 | finance.yahoo.com

NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

August 9, 2022 | msn.com

NeuroOne Seeks Again FDA Clearance For sEEG Electrode In Brain Mapping Diagnostics

August 9, 2022 | finance.yahoo.com

NeuroOne Medical Shares Fall After EEG Electrode Regulatory Update

August 9, 2022 | nasdaq.com

NeuroOne Re-submits Application For SEEG Electrode To Extend Duration Of Use

August 9, 2022 | finance.yahoo.com

NeuroOne® Submits Special 510(k) to FDA for Evo® sEEG Electrode

August 5, 2022 | uk.investing.com

Why NeuroOne Medical Technologies Shares Are Rising

August 4, 2022 | finance.yahoo.com

NeuroOne® to Report Third Quarter Fiscal Year 2022 Financial Results on August 11

August 3, 2022 | finance.yahoo.com

NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode

July 12, 2022 | finance.yahoo.com

NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode

June 2, 2022 | finance.yahoo.com

NeuroOne® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of Stockholders

May 19, 2022 | msn.com

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.75%

May 19, 2022 | finance.yahoo.com

NeuroOne® to Present Its Breakthrough Technology for Monitoring Neural Activity at the H.C. Wainwright Global Investment Conference on May 25

May 17, 2022 | finance.yahoo.com

FDA Denies Approval For NeuroOne Medical's Evo sEEG Electrode For Extended Use

May 16, 2022 | finance.yahoo.com

NeuroOne Provides Evo® sEEG Update

May 13, 2022 | seekingalpha.com

NeuroOne Medical FQ2 Net Loss of $3.1M

May 13, 2022 | finance.yahoo.com

NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

May 3, 2022 | finance.yahoo.com

NeuroOne® to Report Second Quarter Fiscal Year 2022 Financial Results on May 12

April 18, 2022 | finance.yahoo.com

NeuroOne® to Present its Disruptive Next-Generation Diagnostic Electrode Technology at the NobleCon18 Investor Conference on April 20, 2022

March 29, 2022 | marketwatch.com

NeuroOne Medical Shares Plummet as FDA Rejects Longer Electrode Use >NMTC

March 28, 2022 | msn.com

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.27%

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive NMTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

NMTC Company Calendar

Last Earnings: 8/11/2022
Today: 9/28/2022
Fiscal Year End: 9/30/2022
Next Earnings (Estimated): 12/21/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:NMTC
CUSIP: N/A
CIK: 1500198
Web: www.originalsourcemusic.com
Phone: (952) 426-1383
Fax: N/A
Employees: 2,019
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $2.63
High Stock Price Forecast: $3.25
Low Stock Price Forecast: $2.00
Forecasted Upside/Downside: +52.6%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.76)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-9,950,000.00
Net Margins: -7,177.71%
Pretax Margin: -7,177.07%
Return on Equity: -97.47%
Return on Assets: -88.76%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 13.41
Quick Ratio: 12.85

Sales & Book Value

Annual Sales: $180,000.00
Price / Sales: 154.89
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.55 per share
Price / Book: 3.13

Miscellaneous

Outstanding Shares: 16,209,000
Free Float: 14,977,000
Market Cap: $27.88 million
Optionable: Not Optionable
Beta: -0.48

Key Executives

Mr. David A. Rosa M.D. (Age 58)
Pres, CEO & Director
Comp: $603.45k

Mr. Ronald W. McClurg (Age 63)
Chief Financial Officer
Comp: $294.47k

Mr. Steven Mertens (Age 59)
Chief Technology Officer
Comp: $298.97k

Mr. Mark Christianson (Age 55)
Co-Founder, Bus. Devel. Director & Medical Sales Liaison

Mr. Hijaz Haris
VP of Marketing

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NMTC Stock - Frequently Asked Questions

Should I buy or sell NeuroOne Medical Technologies stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NeuroOne Medical Technologies in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NMTC shares.
View NMTC analyst ratings or view top-rated stocks.
What is NeuroOne Medical Technologies' stock price forecast for 2022?: 2 Wall Street research analysts have issued 1-year target prices for NeuroOne Medical Technologies' stock. Their NMTC share price forecasts range from $2.00 to $3.25. On average, they anticipate the company's share price to reach $2.63 in the next twelve months. This suggests a possible upside of 50.0% from the stock's current price.
View analysts price targets for NMTC or view top-rated stocks among Wall Street analysts.
How have NMTC shares performed in 2022?: NeuroOne Medical Technologies' stock was trading at $1.94 at the beginning of the year. Since then, NMTC stock has decreased by 9.8% and is now trading at $1.75.
View the best growth stocks for 2022 here.
When is NeuroOne Medical Technologies' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, December 21st 2022.
View our NMTC earnings forecast.
How were NeuroOne Medical Technologies' earnings last quarter?: NeuroOne Medical Technologies Co. (NASDAQ:NMTC) announced its earnings results on Thursday, August, 11th. The company reported ($0.17) earnings per share for the quarter. The firm had revenue of $0.03 million for the quarter. NeuroOne Medical Technologies had a negative trailing twelve-month return on equity of 97.47% and a negative net margin of 7,177.71%.

What is NeuroOne Medical Technologies' stock symbol?: NeuroOne Medical Technologies trades on the NASDAQ under the ticker symbol "NMTC."
Who are NeuroOne Medical Technologies' major shareholders?: NeuroOne Medical Technologies' stock is owned by many different institutional and retail investors. Top institutional investors include Kingsbury Capital Investment Advisors LLC (0.33%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Mark Christianson and Ronald W Mcclurg.
View institutional ownership trends.
How do I buy shares of NeuroOne Medical Technologies?: Shares of NMTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is NeuroOne Medical Technologies' stock price today?: One share of NMTC stock can currently be purchased for approximately $1.75.
How much money does NeuroOne Medical Technologies make?: NeuroOne Medical Technologies (NASDAQ:NMTC) has a market capitalization of $28.37 million and generates $180,000.00 in revenue each year. The company earns $-9,950,000.00 in net income (profit) each year or ($0.76) on an earnings per share basis.
How many employees does NeuroOne Medical Technologies have?: The company employs 2,019 workers across the globe.
How can I contact NeuroOne Medical Technologies?: NeuroOne Medical Technologies' mailing address is 10006 Liatris Ln, EDEN PRAIRIE, MN 55347-1210, United States. The official website for the company is www.originalsourcemusic.com. The company can be reached via phone at (952) 426-1383 or via email at james@haydenir.com.

This page (NASDAQ:NMTC) was last updated on 9/28/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

NeuroOne Medical Technologies - NMTC Stock Forecast, Price & News

NeuroOne Medical Technologies MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows